3-(Furan-2-ylmethylene)-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylic acid, 98%, 250mg

Plan PLPH 10x/0.25 phase contrast objective

4-Bromo-3-fluorophenol, 98.0%, 10g

1-methyl-1H-pyrazolo[4,3-c]pyridin-4-amine, 95.0%, 1g

(S,E)-Methyl 2-amino-4-(4-(trifluoromethyl)phenyl)but-3-enoate hydrochloride, 97%, 100mg

4-Chloro-3-(trifluoromethoxy)benzonitrile, 97.0%, 1g

DIPHENYL ADIPATE, 95%, 1g

5-(3,4-Dichloro-phenyl)-1 H -pyrazole-3-carboxylic acid, 95.0%, 1g

4-Acetoxyaniline, 97%, 25g

L-tert-Leucinol, 95.0%, 10g

JSH-23, 95.0%, 50mg

(S)-1-Pyrrolidin-2-isopropyl-2-(N-Cbz-N-methyl)amino-ethane, 97.0%, 250mg

1-(4-chlorophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g